Ayunova Pharmaceutical LLP

Product Name

HCG (Human Chorionic Gonadotropin) for Injection BP

Product Description

HCG for Injection BP is a glycoprotein hormone-based injectable used primarily in fertility and reproductive health treatments. It mimics luteinizing hormone (LH) and stimulates ovulation in women and testosterone production in men, making it an essential medication in assisted reproductive therapy (ART) and endocrine disorders.

This sterile injectable formulation is designed for intramuscular (IM) or subcutaneous (SC) administration and is widely used in fertility clinics, hospitals, and specialized reproductive health centers.

Composition

Each vial contains:

• Human Chorionic Gonadotropin (HCG) BP – 5000 IU / 10000 IU

• Excipients: q.s. sterile water for injection (lyophilized powder)

After reconstitution, it is ready for intramuscular or subcutaneous injection.

Major Indications / Uses Female Reproductive Health

• Induction of ovulation in women with anovulatory infertility (e.g., PCOS)

• Assisted reproductive technology (ART) protocols such as IVF and IUI

• Luteal phase support in ovulation induction cycles

Male Reproductive Health

• Stimulation of testosterone production in men with hypogonadotropic hypogonadism

• Treatment of delayed puberty in males due to LH deficiency

Other Uses

• Support in controlled ovarian hyperstimulation for assisted conception

• Adjunct therapy in fertility management protocols

Dosage & Administration

• Route: Intramuscular (IM) or subcutaneous (SC) injection

• Dose (Women): Typically 5000–10000 IU per injection, as per ovulation induction protocol

• Dose (Men): Typically 1000–5000 IU 2–3 times weekly, per endocrinologist’s recommendation

• Monitoring: Ovulation, hormonal levels, and fertility treatment response

⚠ Administer only under supervision of a fertility specialist or endocrinologist

Packaging Details

• Available strengths: 5000 IU and 10000 IU vials

• Lyophilized powder for reconstitution

• Bulk and hospital packaging available

Storage Conditions

• Store 2–8°C (Refrigerated)

• Protect from light and moisture

• Do not freeze

• Keep out of reach of children

ENDOGEST – Progesterone Capsules 200 mg Product Description

ENDOGEST Capsules contain Progesterone, a natural female hormone essential for regulation of ovulation and menstruation and for maintaining pregnancy. It is widely used in gynecological and assisted reproductive treatments to support the luteal phase and prevent progesterone deficiency. The capsules are intended for oral or vaginal use, strictly as prescribed by a gynecologist.

Composition

Each soft gelatin capsule contains:

• Progesterone IP – 200 mg

• Excipients – q.s.

• Dosage Form: Soft gelatin capsule

Uses / Indications

ENDOGEST Capsules are indicated for:

• Luteal phase support in infertility and IVF treatments

• Progesterone deficiency states

• Prevention of preterm labor (as advised)

• Support of early pregnancy

• Menstrual disorders related to hormonal imbalance

Dosage & Administration

• For oral or vaginal use, as prescribed

• Dosage and duration determined by a gynecologist

• Use exactly as directed for best therapeutic outcome

Key Features

• Natural micronized progesterone

• Essential hormone support in pregnancy and IVF

• Well-absorbed soft gelatin formulation

• IP-grade quality

Storage Instructions

• Store below 25°C

• Protect from light and moisture

• Keep out of reach of children

Product Description

Progesterone Injection BP – GESTONE 100 mg/2 ml is a hormonal preparation containing natural progesterone used for hormone replacement therapy, menstrual disorders, and assisted reproductive treatments. Progesterone helps in maintaining the luteal phase of the menstrual cycle, supporting early pregnancy, and regulating hormonal balance. The injectable form ensures rapid and effective absorption.

Composition

Each 2 ml ampoule contains:

• Progesterone BP / USP – 100 mg

• Suitable oil-based vehicle – q.s.

• Excipients – q.s.

Uses / Indications

GESTONE Progesterone Injection 100 mg/2 ml is indicated for:

• Luteal phase support in assisted reproductive technology (ART) protocols

• Prevention of threatened miscarriage in early pregnancy

• Amenorrhea or menstrual irregularities

• Hormone replacement therapy (HRT) in postmenopausal women

• Other gynecological conditions as prescribed

Dosage & Administration

• Administered intramuscularly as prescribed by the physician

• Common dose: 100 mg daily or as directed, depending on indication

• Injection should be given deep intramuscularly using aseptic technique

• Dosage adjustments may be required based on clinical response

Storage Instructions

• Store below 25°C

• Protect from light and moisture

• Keep out of reach of children

Packaging

• 2 ml ampoule

• Strength: 100 mg per 2 ml

• Pack size: As per manufacturer

Product Description

Menopur 75 IU is a highly purified human menopausal gonadotropin (hMG) preparation containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH). It is used for controlled ovarian stimulation in assisted reproductive technology (ART) protocols. Menopur helps in stimulating follicular development, optimizing ovulation, and increasing the chances of successful conception. The preparation is intended for subcutaneous or intramuscular administration under medical supervision.

Composition

Each vial contains:

• Human Menopausal Gonadotropins (hMG) IP / USP – 75 IU (FSH and LH combined)

• Lyophilized powder for reconstitution

• Excipients – q.s.

Uses / Indications

Menopur 75 IU is indicated for:

• Controlled ovarian stimulation (COS) in women undergoing IVF or ICSI procedures

• Treatment of anovulation or oligo-ovulation due to pituitary or ovarian dysfunction

• Assisted reproduction protocols requiring gonadotropin stimulation

• Other fertility treatments as prescribed by the clinician

Dosage & Administration

• Administered subcutaneously or intramuscularly after reconstitution with the provided sterile diluent

• Dosage and duration depend on patient’s ovarian reserve, response, and ART protocol

• Use aseptic technique during reconstitution and injection

• Follow physician’s instructions carefully

Storage Instructions

• Store unreconstituted vials at 2–8°C, protected from light

• Do not freeze

• Keep out of reach of children

• Reconstituted solution should be used immediately or as per manufacturer instructions

Packaging

• Lyophilized vial with sterile diluent

• Strength: 75 IU

• Pack size: As per manufacturer

Product Description

Menotropin Injection IP 75 IU is a highly purified human menopausal gonadotropin (hMG) preparation containing both follicle-stimulating hormone (FSH) and luteinizing hormone (LH). It is primarily used for controlled ovarian stimulation (COS) in assisted reproductive technology (ART) protocols. Menotropin promotes follicular development and maturation, optimizing the chances of successful conception. The injection is intended for subcutaneous or intramuscular administration under medical supervision.

Composition

Each vial contains:

• Menotropins (hMG) IP / USP – 75 IU (FSH + LH)

• Lyophilized powder for reconstitution

• Excipients – q.s.

Uses / Indications

Menotropin Injection 75 IU is indicated for:

• Controlled ovarian stimulation (COS) in women undergoing IVF or ICSI procedures

• Treatment of anovulation or oligo-ovulation caused by pituitary or ovarian dysfunction

• Assisted reproduction protocols requiring gonadotropin stimulation

• Other fertility treatments as prescribed by the clinician

Dosage & Administration

• Administered subcutaneously or intramuscularly after reconstitution with the provided sterile diluent

• Dosage and duration depend on patient’s ovarian reserve, response, and ART protocol

• Use aseptic technique during reconstitution and injection

• Follow physician’s instructions carefully

Storage Instructions

• Store unreconstituted vials at 2–8°C, protected from light

• Do not freeze

• Keep out of reach of children

• Reconstituted solution should be used immediately or as per manufacturer instructions

Packaging

• Lyophilized vial with sterile diluent

• Strength: 75 IU per vial

• Pack size: As per manufacturer

Product Description

Follicle Stimulating Hormone (FSH) Injection IP 450 IU / 0.75 ml is a highly purified recombinant human follicle-stimulating hormone used in assisted reproductive technology (ART). It stimulates ovarian follicular development in women undergoing fertility treatments and supports spermatogenesis in men with hypogonadotropic hypogonadism. The prefilled pen formulation allows accurate dosing and convenient subcutaneous administration under medical supervision.

Composition

Each 0.75 ml prefilled pen contains:

• Recombinant Human Follicle Stimulating Hormone IP – 450 IU

• Buffer solution and excipients – q.s.

Uses / Indications

FSH Injection IP 450 IU / 0.75 ml is indicated for:

• Controlled ovarian stimulation (COS) in women undergoing IVF / ICSI

• Ovulation induction in anovulatory infertility

• Assisted reproductive technology (ART) protocols

• Stimulation of spermatogenesis in men with gonadotropin deficiency

Dosage & Administration

• Administered subcutaneously using the prefilled pen

• Dosage and duration depend on patient response, ovarian reserve, and treatment protocol

• Use strictly as prescribed by a fertility specialist

• Rotate injection sites to minimize local reactions

Storage Instructions

• Store at 2–8°C (refrigerated)

• Do not freeze

• Protect from light

• After first use, store as per manufacturer’s instructions

Packaging

• Prefilled injection pen

• Strength: 450 IU / 0.75 ml

• Pack includes pen with disposable needles (as per manufacture

Product Description

Follicle Stimulating Hormone (FSH) Injection IP 900 IU / 1.5 ml is a highly purified recombinant human follicle-stimulating hormone used in assisted reproductive technology (ART). It stimulates ovarian follicular growth and maturation in women undergoing fertility treatment and supports spermatogenesis in men with gonadotropin deficiency. The prefilled pen formulation allows precise dose adjustment and convenient subcutaneous administration under medical supervision.

Composition

Each 1.5 ml prefilled pen contains:

• Recombinant Human Follicle Stimulating Hormone IP – 900 IU

• Buffer solution and excipients – q.s.

Uses / Indications

FSH Injection IP 900 IU / 1.5 ml is indicated for:

• Controlled ovarian stimulation (COS) in IVF / ICSI procedures

• Ovulation induction in women with anovulatory infertility

• Assisted reproductive technology (ART) protocols

• Induction of spermatogenesis in men with hypogonadotropic hypogonadism

Dosage & Administration

• Administered subcutaneously using the prefilled pen device

• Dosage and duration depend on ovarian response, patient age, and treatment protocol

• Use strictly as prescribed by a fertility specialist

• Rotate injection sites to reduce local irritation

Storage Instructions

• Store at 2–8°C (refrigerated)

• Do not freeze

• Protect from light

• After first use, store as per manufacturer’s instructions

Packaging

• Prefilled injection pen

• Strength: 900 IU / 1.5 ml

Product Description

Follicle Stimulating Hormone (FSH) Injection IP 300 IU / 0.5 ml is a highly purified recombinant human follicle-stimulating hormone used in assisted reproductive technology (ART). It stimulates ovarian follicular development and maturation in women undergoing fertility treatment and is also used to support spermatogenesis in men with gonadotropin deficiency. The prefilled pen formulation ensures accurate dosing and convenient subcutaneous administration under medical supervision.

Composition

Each 0.5 ml prefilled pen contains:

• Recombinant Human Follicle Stimulating Hormone IP – 300 IU

• Buffer solution and excipients – q.s.

Uses / Indications

FSH Injection IP 300 IU / 0.5 ml is indicated for:

• Controlled ovarian stimulation (COS) in IVF / ICSI cycles

• Ovulation induction in anovulatory infertility

• Assisted reproductive technology (ART) protocols

• Stimulation of spermatogenesis in men with hypogonadotropic hypogonadism

Dosage & Administration

• Administered subcutaneously using the prefilled pen

• Dosage and duration depend on patient age, ovarian reserve, and treatment protocol

• Use strictly as prescribed by a fertility specialist

• Rotate injection sites to minimize local reactions

Storage Instructions

• Store at 2–8°C (refrigerated)

• Do not freeze

• Protect from light

• After first use, store as per manufacturer’s instructions

Packaging

• Prefilled injection pen

• Strength: 300 IU / 0.5 m

Product Description

Follitropin Alfa and Lutropin Alfa Injection 450 IU + 225 IU / 0.72 ml is a recombinant gonadotropin combination containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH). It is used in assisted reproductive technology (ART) for women with severe LH and FSH deficiency, helping to stimulate optimal follicular development and ovulation. The prefilled pen formulation ensures accurate dosing and convenient subcutaneous administration under specialist supervision.

Composition

Each 0.72 ml prefilled pen contains:

• Follitropin Alfa (r-hFSH) IP / USP – 450 IU

• Lutropin Alfa (r-hLH) IP / USP – 225 IU

• Buffer solution and excipients – q.s.

Uses / Indications

Follitropin Alfa & Lutropin Alfa Injection is indicated for:

• Controlled ovarian stimulation (COS) in women undergoing IVF / ICSI

• Treatment of women with severe LH and FSH deficiency

• Assisted reproductive technology (ART) protocols

• Promotion of follicular growth and ovulation induction

Dosage & Administration

• Administered subcutaneously using the prefilled pen device

• Dosage and duration are determined by the fertility specialist based on patient response

• Use strictly as prescribed

• Rotate injection sites to reduce local reactions

Storage Instructions

• Store at 2–8°C (refrigerated)

• Do not freeze

• Protect from light

• After first use, store as per manufacturer’s instructions

Packaging

• Prefilled injection pen

• Strength: 450 IU FSH + 225 IU LH / 0.72 ml

Product Description

Follitropin Alfa and Lutropin Alfa Injection 900 IU + 450 IU / 1.44 ml is a recombinant gonadotropin combination containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH). It is specifically indicated for women with severe FSH and LH deficiency undergoing assisted reproductive technology (ART). The formulation supports optimal follicular development, estrogen production, and ovulation induction. The prefilled pen ensures accurate dosing and convenient subcutaneous administration under fertility specialist supervision.

Composition

Each 1.44 ml prefilled pen contains:

• Follitropin Alfa (r-hFSH) IP / USP – 900 IU

• Lutropin Alfa (r-hLH) IP / USP – 450 IU

• Buffer solution and excipients – q.s.

Uses / Indications

Follitropin Alfa & Lutropin Alfa Injection is indicated for:

• Controlled ovarian stimulation (COS) in IVF / ICSI cycles

• Women with severe LH and FSH deficiency

• Assisted reproductive technology (ART) protocols

• Promotion of follicular growth, maturation, and ovulation

Dosage & Administration

• Administered subcutaneously using the prefilled pen device

• Dosage and treatment duration are determined by the fertility specialist based on patient response

• Use strictly as prescribed

• Rotate injection sites to minimize local irritation

Storage Instructions

• Store at 2–8°C (refrigerated)

• Do not freeze

• Protect from light

• After first use, store as per manufacturer’s instructions

Packaging

• Prefilled injection pen

• Strength: 900 IU FSH + 450 IU LH / 1.44 ml